Your browser doesn't support javascript.
loading
Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial.
Requena-Ibáñez, Juan Antonio; Santos-Gallego, Carlos García; Rodriguez-Cordero, Anderly; Vargas-Delgado, Ariana Patricia; Badimón, Juan José.
Afiliação
  • Requena-Ibáñez JA; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Electronic address: juan.antonio.requena.ib@gmail.com.
  • Santos-Gallego CG; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Rodriguez-Cordero A; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Vargas-Delgado AP; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Badimón JJ; Atherothrombosis Research Unit, New York, NY, United States; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Diabetes Metab Syndr ; 16(2): 102417, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35121204
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article